Deep search
All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Edwards Lifesciences, TAVR
Edwards Lifesciences Is Poised For Solid Growth In 2025—Analyst Highlights TAVR Growth, Margin Expansion
Edwards Lifesciences shares rise as analyst upgrades stock, citing TAVR growth, margin expansion, and strategic business changes for 2025.
Edwards Lifesciences upped to Buy at Stifel on TAVR growth
Edwards Lifesciences (NYSE:EW) traded higher on Thursday after Stifel upgraded the heart device maker to Buy from Hold, citing a turnaround in its position in the market for transcatheter aortic valve replacement (TAVR).
Edwards Lifesciences Q4 Earnings Set to Benefit From TAVR Growth
Favorable hospitalization trend, strong adoption of transcatheter heart valves and improved procedural volume are expected to have aided EW in the fourth quarter.
Edwards Lifesciences upgraded to Buy from Hold at Stifel
Stifel analyst Rick Wise upgraded Edwards Lifesciences (EW) to Buy from Hold with a price target of $90, up from $75. The firm said that TAVR,
Stifel raises Edwards Lifesciences stock to buy, target to $90
Stifel analysts upgraded Edwards Lifesciences (NYSE:EW) stock from Hold to Buy, citing potential growth acceleration in the Transcatheter Aortic Valve Replacement (TAVR) market. The firm also increased its price target on the company from $75.
Healio
1d
CABG plus surgical AVR may suit certain older patients with aortic stenosis, CAD
CABG plus surgical aortic valve replacement for treatment of coronary disease and aortic stenosis was associated with better 5-year outcomes vs. PCI plus transcatheter aortic valve replacement in ...
Hosted on MSN
3d
Caranx Medical submits AI TAVI-TAVR guide software to FDA
TAVIPILOT Soft is said to be a ‘world-first’ provision for real-time surgical guidance during TAVI and TAVR procedures.
The Valdosta Daily Times
11d
SGMC Health performs its first alternative access Transcatheter Aortic Valve Replacement
SGMC Health recently achieved the successful completion of its first transcarotid access Transcatheter Aortic Valve ...
MassDevice
9d
Analysts expect JenaValve TAVR approval for aortic regurgitation in 2025
GlobalData analysts anticipate FDA approval for the JenaValve Trilogy TAVR device designed to treat aortic regurgitation (AR) ...
9d
JenaValve Trilogy System’s FDA approval to expand indications to aortic regurgitation
The US Food and Drugs Administration (FDA) is expected to approve the JenaValve Trilogy System, a transcatheter aortic valve ...
Medical Design and Outsourcing
6d
What is minimally invasive medtech? Device experts offer their thoughts
Minimally invasive medtech can include surgical robots, miniaturized implants and therapeutic catheters — but it depends who ...
10d
on MSN
What you need to know about the silent threat of aortic stenosis?
Aortic stenosis, affecting nine million people globally, is often unnoticed as symptoms are mistaken for aging. This heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Edwards Lifesciences
Stifel
Army Reserve
Feedback